140
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Exploring Interleukin-10 Levels in Diabetes Patients with and without Oral Diseases: A Systematic Review

ORCID Icon & ORCID Icon
Pages 541-552 | Received 20 Nov 2023, Accepted 23 Jan 2024, Published online: 31 Jan 2024

References

  • Alam S, Hasan MK, Neaz S, Hussain N, Hossain MF, Rahman T. Diabetes mellitus: insights from epidemiology, biochemistry, risk factors, diagnosis, complications and comprehensive management. Diabetology. 2021;2(2):36–50. doi:10.3390/diabetology2020004
  • Loscalzo J, Kasper DL, Longo DL, Fauci AS, Hauser SL, Jameson JL. Harrison’s Principles of Internal Medicine. 21st ed. McGraw Hill LLC; 2022.
  • Al Shihi N, Al Rawahi A, Al Jahdhami R. Oral health knowledge, attitudes, and practices of individuals with diabetes mellitus in the Sultanate of Oman. Dubai Diabetes Endocrinol J. 2023;29(1):33–41. doi:10.1159/000529684
  • Indrahadi D, Wardana A, Pierewan AC. The prevalence of diabetes mellitus and relationship with socioeconomic status in the Indonesian population. J Gizi Klin Indones. 2021;17(3):103–112. doi:10.22146/ijcn.55003
  • IDF. Diabetes around the world in 2021. IDF Diabetes Atlas Report 2022; 2022. Available from: https://diabetesatlas.org/. Accessed August 20, 2023.
  • ElSayed NA, Aleppo G, Aroda VR, et al; ADA. Classification and diagnosis of diabetes: standards of care in diabetes — 2023. Diabetes Care. 2023;46(1):19–40. doi:10.2337/dc23-S002
  • Glick M, Greenberg M, Lockhart P, et al. Burket’s Oral Medicine. Vol. 4. 13th ed. John Wiley & Sons Inc; 2021.
  • Ongole R, P BN. Textbook of Oral Medicine, Oral Diagnosis and Oral Radiology. 2nd ed. Elsevier; 2013.
  • Neville BW, Damm DD, Allen CM, Chi AC. Color Atlas of Oral and Maxillofacial Diseases. Elsevier Inc.; 2019.
  • Ghom AG, Ghom SA. Textbook of Oral Medicine. 3th ed. Jaypee Brothers Medical Publishers; 2014. doi:10.5005/jp/books/12631_48
  • Miller C, Rhodus NL, Treister NS, Stoopler ET, Kerr AR. Little and Falace’s Dental Management of the Medically Compromised Patient. Elsevier Health Sciences; 2018; doi:10.1016/B978-0-323-28745-6.00026-0
  • Melmed S, Koenig RJ, Auchus RJ, Rosen CJ, Goldfine AB. Williams Textbook of Endocrinology. 14th ed. Elsevier; 2020.
  • Arthur C, Guyton MD, John E, Hall PD. Textbook of Medical Physiology. Elsevier; 2006.
  • Khin PP, Lee JH, Sook JH. Pancreatic beta-cell dysfunction in type 2 diabetes. Eur J Inflamm. 2023;21:1–13. doi:10.1177/1721727X231154152
  • Kumar V, Abbas AK, Aster. JC. Robbins Basic Pathology. Vol. 4. 10th ed. Elsevier; 2019
  • Verhulst MJL, Loos BG, Gerdes VEA, Teeuw WJ. Evaluating all potential oral complications of diabetes mellitus. Front Endocrinol. 2019;10(FEB). doi:10.3389/fendo.2019.00056
  • Rayego-Mateos S, Morgado-Pascual JL, Opazo-Ríos L, et al. Pathogenic pathways and therapeutic approaches targeting inflammation in diabetic nephropathy. Int J Mol Sci. 2020;21(11):1–43. doi:10.3390/ijms21113798
  • Kapila YL. Oral health’s inextricable connection to systemic health: special populations bring to bear multimodal relationships and factors connecting periodontal disease to systemic diseases and conditions. Periodontology 2000. 2021;87(1):11–16. doi:10.1111/prd.12398
  • Borgnakke WS, Poudel P. Diabetes and oral health: summary of current scientific evidence for why transdisciplinary collaboration is needed. Front Dent Med. 2021;2(1–13). doi:10.3389/fdmed.2021.709831
  • Homagarani YM, Adlparvar K, Teimuri S, Tarrahi MJ, Nilchian F. The effect of diabetes mellitus on oral health-related quality of life: a systematic review and meta-analysis study. Front Public Health. 2023;11:1112008. doi:10.3389/fpubh.2023.1112008
  • Kane SF. The effects of oral health on systemic health. Acad Gen Dent. 2017;65(6):30–34.
  • Kumari S, Gnanasundaram N. Oral manifestations in diabetes mellitus ‑ a review. J Indian Acad Oral Med Radiol. 2021;33(4):352–356. doi:10.4103/jiaomr.jiaomr
  • Rohani B. Oral manifestations in patients with diabetes mellitus. World J Diabetes. 2019;10(9):485–489. doi:10.4239/wjd.v10.i9.485
  • Indurkar MS, Maurya AS, Indurkar S. Oral manifestations of diabetes. Clin Diabetes. 2016;34(1):54–57. doi:10.2337/diaclin.34.1.54
  • Duarte PM, Neto JBC, Casati MZ, Sallum EA, Nociti FH. Diabetes modulates gene expression in the gingival tissues of patients with chronic periodontitis. Oral Dis. 2007;13(6):594–599. doi:10.1111/j.1601-0825.2006.01348.x
  • Saraiva M, Vieira P, Garra AO. Biology and therapeutic potential of interleukin-10. J Exp Med. 2019;216(1):1–19. doi:10.1084/jem.20181961
  • Ma X. Regulation of Cytokine Gene Expression in Immunity and Diseases. Springer Nature; 2016.
  • Scully C. Oral and Maxillofacial Medicine. Elsevier; 2013; doi:10.1111/j.1601-0825.2008.01461.x
  • Slavin AJ, Maron R, Weiner HL. Mucosal administration of IL-10 enhances oral tolerance in autoimmune encephalomyelitis and diabetes. Int Immunol. 2001;13(6):825–833. doi:10.1093/intimm/13.6.825
  • Lu J, Liu J, Li L, Lan Y, Liang Y. Cytokines in type 1 diabetes: mechanisms of action and immunotherapeutic targets. Clin Transl Immunol. 2020;9(3):1–17. doi:10.1002/cti2.1122
  • Iyer SS, Cheng G. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol. 2013;32(1):23–63. doi:10.1615/CritRevImmunol.v32.i1.30
  • Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R. Type 2 diabetes and its impact on the immune system. Curr Diabetes Rev. 2020;16(5):442–449. doi:10.2174/1573399815666191024085838
  • Xu A, Zhu W, Li T, et al. Interleukin-10 gene transfer into insulin-producing β cells protects against diabetes in non-obese diabetic mice. Mol Med Rep. 2015;12(3):3881–3889. doi:10.3892/mmr.2015.3809
  • Andriankaja OM, Adatorwovor R, Kantarci A, Hasturk H, Shaddox L, Levine MA. Periodontal disease, local and systemic inflammation in Puerto Ricans with type 2 diabetes mellitus. Biomedicines. 2023;11(10):1–15. doi:10.3390/biomedicines11102770
  • Ikbal SKA, Gupta S, Tiwari V, Dhinsa G, Verma N. Association of serum interleukin-10 level with glycemic status to predict glycemic alteration with periodontitis: a cross-sectional, observational study. Contemp Clin Dent. 2023;8:11–19. doi:10.4103/ccd.ccd
  • Halimi A, Mortazavi N, Memarian A, Zahedi M, Niknejad F, Sohrabi A. The relation between serum levels of interleukin 10 and interferon ‑ gamma with oral candidiasis in type 2 diabetes mellitus patients. BMC Endocr Disord. 2022;22(1):1–6. doi:10.1186/s12902-022-01217-x
  • Liu L, Xiao Z, Ding W, et al. Relationship between microRNA expression and inflammatory factors in patients with both type 2 diabetes mellitus and periodontal disease. Am J Transl Res. 2022;14(9):6627–6637.
  • Zhang H, Zhang Y, Chen X, Li J, Zhang Z, Yu H. Effects of statins on cytokines levels in gingival crevicular fluid and saliva and on clinical periodontal parameters of middle-aged and elderly patients with type 2 diabetes mellitus. PLoS One. 2021;16:1–18. doi:10.1371/journal.pone.0244806
  • Elazazy O, Amr K, Abd El Fattah A, Abouzaid M. Evaluation of serum and gingival crevicular fluid microRNA-223, microRNA-203 and microRNA-200b expression in chronic periodontitis patients with and without diabetes type 2. Arch Oral Biol. 2021;121:104949. doi:10.1016/j.archoralbio.2020.104949
  • Rangel TP, Reis AA, Caponi L, et al. Subgingival endotoxin and lipoteichoic acid modulate cytokine production in diabetic subjects: a Case–control Study. Oral Dis. 2021;27(5):1325–1333. doi:10.1111/odi.13661
  • Kassab A, Ayed Y, Elsayed SA, et al. Glycated hemoglobin influence on periodontal status, pathogens and salivary interleukins in type II diabetic Tunisian subjects with chronic periodontitis. J Dent Sci. 2021;16(2):614–620. doi:10.1016/j.jds.2020.09.018
  • de Sousa Rabelo M, Gomes GH, Foz AM, et al. Short-term effect of non-surgical periodontal treatment on local and systemic cytokine levels: role of hyperglycemia. Cytokine. 2021;138:155360. doi:10.1016/j.cyto.2020.155360
  • Kumar PS, Monteiro MF, Dabdoub SM, et al. Subgingival host-microbial interactions in hyperglycemic individuals. J Dent Res. 2020;99(6):650–657. doi:10.1177/0022034520906842
  • Belkina AC, Azer M, Lee JJ, et al. Single-cell analysis of the periodontal immune niche in type 2 diabetes. J Dent Res. 2020;99(7):855–862. doi:10.1177/0022034520912188
  • Chinaarkatakul K, Loakhajorn K. Diabetes mellitus: a leading cause of death worldwide. Int J Curr Sci Res Rev. 2023;06(08):5640–5646. doi:10.47191/ijcsrr/V6-i8-31
  • de la Rosa García E, Mondragón Padilla A, Aranda Romo S, Bustamante Ramírez MA. Oral mucosa symptoms, signs and lesions, in end stage renal disease and non-end stage renal disease diabetic patients. Med Oral Patol Oral Cir Bucal. 2006;11(6):E467–E673.
  • Elad S, Zadik Y, Caton JG, Epstein JB. Oral mucosal changes associated with primary diseases in other body systems. Periodontol 2000. 2019;80(1):28–48. doi:10.1111/prd.12265
  • Sanjeeta N, Sivapathasundharam B, Nandini DB. Oral lesions and periodontal status in diabetics and non ‑ diabetics: a hospital based study. J Oral Maxillofac Pathol. 2022;26(419):1–6. doi:10.4103/jomfp.jomfp
  • Miguel Á, Ramos-Garcia P. State of evidence on oral health problems in diabetic patients: a critical review of the literature. J Clin Med Rev. 2021;10(22):5383.
  • Sun J, Chen T, Zhao B, et al. Acceleration of oral wound healing under diabetes mellitus conditions using bioadhesive hydrogel. ACS Appl Mater Interfaces Against. 2023;15(1):416–431. doi:10.1021/acsami.2c17424
  • Tsalamandris S, Antonopoulos AS, Oikonomou E, et al. The role of inflammation in diabetes: current concepts and future perspectives. Eur Cardiol Rev. 2019;14(1):50–59. doi:10.15420/ecr.2018.33.1
  • Lontchi-Yimagou E, Sobngwi E, Matsha TE, Kengne AP. Diabetes mellitus and inflammation. Curr Diab Rep. 2013;13(3):435–444. doi:10.1007/s11892-013-0375-y